A carregar...
New Therapeutic Approaches to Modulate and Correct CFTR
Personalized medicines are now available for over half the cystic fibrosis (CF) population with genotype-directed therapies that target the underlying defect of CF, abnormal cystic fibrosis transmembrane conductance regulator (CFTR) protein. This review summarizes current strategies that have been t...
Na minha lista:
| Publicado no: | Pediatr Clin North Am |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5478192/ https://ncbi.nlm.nih.gov/pubmed/27469186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pcl.2016.04.006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|